ConductScience.org, home

Paper36070489

Analysis of Orthogonal Efflux and Permeation Properties of Compounds Leads to the Discovery of New Efflux Pump Inhibitors.

Moniruzzaman M and 5 others. ACS Infect Dis, 2022. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Analysis of Orthogonal Efflux and Permeation Properties of Compounds Leads to the Discovery of New Efflux Pump Inhibitors. Papers, record 36070489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36070489

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of Orthogonal Efflux and Permeation Properties of Compounds Leads to the Discovery of New Efflux Pump Inhibitors.
PubMed
Journal
ACS Infect Dis
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2023-10-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moniruzzaman MMohammad
2Cooper CJConnor Jhttps://orcid.org/0000-0002-5527-9948
3Uddin MRMuhammad R
4Walker JKJohn Khttps://orcid.org/0000-0002-8683-0026
5Parks JMJerry Mhttps://orcid.org/0000-0002-3103-9333
6Zgurskaya HIHelen Ihttps://orcid.org/0000-0001-8929-4727

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Escherichia coliMajor topic
Membrane Transport ProteinsMajor topic
Amines
Anti-Bacterial Agents
Porins

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI052293NIAID NIH HHSUnited StatesR01AI052293PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132039579Drug Permeation against Efflux by Two Transporters.ACS Infect Dis2020https://conductscience.org/library/papers/32039579PubMed
219805313Kinetic control of TolC recruitment by multidrug efflux complexes.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19805313PubMed
331792365Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria.Nat Rev Microbiol2020https://conductscience.org/library/papers/31792365PubMed
419399780AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.J Comput Chem2009https://conductscience.org/library/papers/19399780PubMed
531588569AcrB: a mean, keen, drug efflux machine.Ann N Y Acad Sci2020https://conductscience.org/library/papers/31588569PubMed
627768847Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.ACS Infect Dis2017https://conductscience.org/library/papers/27768847PubMed
728926596Bifurcation kinetics of drug uptake by Gram-negative bacteria.PLoS One2017https://conductscience.org/library/papers/28926596PubMed
829756762Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa.ACS Infect Dis2018https://conductscience.org/library/papers/29756762PubMed
926976576Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/26976576PubMed
1022451937Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22451937PubMed
1128224989Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria.Nat Microbiol2017https://conductscience.org/library/papers/28224989PubMed
1228157293Whole-Cell-Based Assay To Evaluate Structure Permeation Relationships for Carbapenem Passage through the Pseudomonas aeruginosa Porin OprD.ACS Infect Dis2017https://conductscience.org/library/papers/28157293PubMed
1329661860Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii.J Bacteriol2018https://conductscience.org/library/papers/29661860PubMed
1433596653The Whole Is Bigger than the Sum of Its Parts: Drug Transport in the Context of Two Membranes with Active Efflux.Chem Rev2021https://conductscience.org/library/papers/33596653PubMed
1529446459The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.Ann N Y Acad Sci2019https://conductscience.org/library/papers/29446459PubMed
1626478537Quantification of Fluoroquinolone Uptake through the Outer Membrane Channel OmpF of Escherichia coli.J Am Chem Soc2015https://conductscience.org/library/papers/26478537PubMed
1729317622Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition.Nat Commun2018https://conductscience.org/library/papers/29317622PubMed
1829089426Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.mBio2017https://conductscience.org/library/papers/29089426PubMed
1925910245Toward the rational design of carbapenem uptake in Pseudomonas aeruginosa.Chem Biol2015https://conductscience.org/library/papers/25910245PubMed
208363364Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8363364PubMed

See all 52 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
40867973Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps.Antibiotics (Basel)2025https://conductscience.org/library/papers/40867973PubMed
39085542Sophisticated natural products as antibiotics.Nature2024https://conductscience.org/library/papers/39085542PubMed
37707450Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability.Microbiol Spectr2023https://conductscience.org/library/papers/37707450PubMed
37371580Efflux Pump-Binding 4(3-Aminocyclobutyl)Pyrimidin-2-Amines Are Colloidal Aggregators.Biomolecules2023https://conductscience.org/library/papers/37371580PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36070489

GET https://conductscience.org/api/papers/v1/36070489/references?page=2